Sorrento Therapeutics Announces Covishield (Sti-9167), a Broad-Spectrum Neutralizing Antibody, Potently Neutralizes Omicron and Omicron (+R346k) Variants of Sars-Cov-2

Press/Media

Period	22 Jan 2022

Media coverage

Title	Sorrento Therapeutics Announces Covishield (Sti-9167), a Broad-Spectrum Neutralizing Antibody, Potently Neutralizes Omicron and Omicron (+R346k) Variants of Sars-Cov-2
Media name/outlet	USA Life Sciences Database
Country/Territory	Switzerland
Date	22/01/22
URL	www.usalifesciences.com/us/portal/news_details.php?news_id=28536651k$SnpKo6I326Akk&page_id=?next=1
Persons	Domenico Tortorella